Kai Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KAI PHARMS INC, and what generic alternatives to KAI PHARMS INC drugs are available?
KAI PHARMS INC has one approved drug.
There are seven US patents protecting KAI PHARMS INC drugs.
There are eighty-eight patent family members on KAI PHARMS INC drugs in forty-four countries and seventeen supplementary protection certificates in fifteen countries.
Drugs and US Patents for Kai Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-001 | Feb 7, 2017 | RX | Yes | Yes | 10,344,765 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-001 | Feb 7, 2017 | RX | Yes | Yes | 8,377,880 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-001 | Feb 7, 2017 | RX | Yes | Yes | 9,701,712 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-002 | Feb 7, 2017 | RX | Yes | Yes | 8,999,932 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-002 | Feb 7, 2017 | RX | Yes | Yes | 8,377,880 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-003 | Feb 7, 2017 | RX | Yes | Yes | 8,377,880 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-002 | Feb 7, 2017 | RX | Yes | Yes | 10,344,765 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Kai Pharms Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Slovenia | 3013318 | ⤷ Try a Trial |
Lithuania | 3013318 | ⤷ Try a Trial |
Hungary | S1700008 | ⤷ Try a Trial |
Portugal | 3013318 | ⤷ Try a Trial |
Luxembourg | C00008 | ⤷ Try a Trial |
Croatia | P20190923 | ⤷ Try a Trial |
Malaysia | 180276 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Kai Pharms Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2459208 | 122017000021 | Germany | ⤷ Try a Trial | PRODUCT NAME: ETELCALCETID ODER EIN SALZ DAVON; REGISTRATION NO/DATE: EU/1/16/1142 20161111 |
2459208 | LUC00008 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: ETELCALCETIDE, OU UN SEL EQUIVALENT, Y COMPRIS LE CHLORHYDRATE D'ETELCALCETIDE (PARSABIV); AUTHORISATION NUMBER AND DATE: EU/1/16/1142 20161115 |
2459208 | 300864 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ETELCALCETIDE OF EEN ZOUT DAARVAN, MET INBEGRIP VAN ETELCALCETIDEHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/16/1142/001-012 20161115 |
2459208 | 1790012-7 | Sweden | ⤷ Try a Trial | PRODUCT NAME: ETELCALCETIDE, OR SALT THEREOF, INCLUDING ETELCALCETIDE HYDROCHLORIDE; REG. NO/DATE: EU/1/16/1142/001-012 20161115 |
2459208 | C02459208/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: ETELCALCETID; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66338 27.09.2017 |
2459208 | 17C1009 | France | ⤷ Try a Trial | PRODUCT NAME: ETELCALCETIDE, OU UN SEL DE CELUI-CI, NOTAMMENT LE CHLORHYDRATE D'ETELCALCETIDE; REGISTRATION NO/DATE: EU/1/16/1142/001-012 20161115 |
2459208 | C20170006 00208 | Estonia | ⤷ Try a Trial | PRODUCT NAME: ETELKALTSETIID;REG NO/DATE: EU/1/16/1142 15.11.2016 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.